Fact CheckerSign in

NCT06313138Completed

Effectiveness of Health Literacy Enhancement Program Among Older Persons With Physical Multimorbidity

Effectiveness of the Individual and Family Health Literacy Enhancement Program Among Older Persons With Physical Multimorbidity

Source: ClinicalTrials.gov · Last updated 15 Mar 2024

Brief summary (registry, in English)

The study aims to examine the effectiveness of individual and family health literacy enhancement program among older persons with physical multimorbidity. Specific objectives are: 1. To compare self-management, treatment burden, and symptom burden of older persons with physical multimorbidity between before and after receiving the individual and family health literacy enhancement program. 2. To compare self-management, treatment burden, and symptom burden of older persons with physical multimorbidity between those receiving the individual and family health literacy enhancement program and those receiving usual care. Participants in the control group will receive usual care by physician and nurses during the experimental period. The usual care consists of physical examination, regular treatment protocol, patient education and telephone follow-up by community nurses. Participants in the interventional group will receive the program which is a group-based intervention developed by the researcher based on the Individual and Family Self-Management Theory (IFSMT) (self-management skills) and the principle of Medagogy (PITS model: Pathophysiology, Indications, Treatments, Specifies) to improve patients' and their families' understanding of disease-related information and self-management skills consisting of goal setting and action plan, self-monitoring, solving problems and decision-making, and emotional control.The program will be divided into 8 sessions. Each session will be lasted for 2 hours with 1 intermittent break (10 minutes), and it will be held twice a week, and the last session will be held 1 week after the 7th session. Therefore, it will last for 5 weeks in total.

Status (registry)
Completed
Study type
Interventional
Enrollment
140 (actual)
First submitted
13 Jan 2024
Start date
15 Jul 2023
Primary completion date
25 Dec 2023
Lead sponsor
Nantong University
NCT number
NCT06313138

What you commit to

  • Study type: Interventional
  • Participants enrolled: 140
  • From 15 Jul 2023 to the primary completion date, 25 Dec 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Having other diseases or severe complications from their health problems that making them unable to fully participate through all process of the program including ischemic heart disease, myocardial infarction, heart failure, stroke, acute renal failure, diabetic ketoacidosis, and diabetic coma;

Who the study is looking for

  • Age 60-80 years old;
  • Having been diagnosed with hypertension and type 2 diabetes for at least 6 months;
  • Being able to read and write Chinese language;
  • Cognitive intact as measured by the Mini-Mental State Examination (MMSE) with the score ≥ 24;
  • Physically independence as measured by the Barthel ADL Index and the score above 12 out of 20 ;
  • Willing to participate in the study;
  • Having at least a family member who is willing to participate in the study.

Age in the registry: 60 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Nantong University
Coordinator of this site? Confirm its status
NantongChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.